<?xml version="1.0" encoding="UTF-8"?>
<fig id="Fig2">
 <label>Fig. 2</label>
 <caption>
  <title>mAb product development for pandemics (mAb lead identification to BLA).</title>
  <p>The fastest path to licensure for therapeutic mAbs treating pandemic outbreaks requires accepting business risks and preinvestment, but without major product quality, supply and regulatory risks.</p>
 </caption>
 <graphic xlink:href="41587_2020_512_Fig2_HTML" id="d29e372" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
